EFFEKTIVNOST' I BEZOPASNOST' TAMSULOZINA DLYa ZhENShchIN S INFRAVEZIKAL'NOY OBSTRUKTsIEY


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

全文:

受限制的访问

参考

  1. Урология: национальное руководство / Под ред. Н. А Лопаткина. ГЭОТАР-МЕДИА, 2009. 1024 с.
  2. Lee K.-S., Han D. H., Lee Y.-S., et al. Efficacy and Safety of Tamsulosin for the Treatment of Non-neurogenic Voiding Dysfunction in Females: A 8-Week Prospective Study. J Korean Med Sci. 2010;25(1):117—122.
  3. Скрябин Г. Н., Александров В. П., Кореньков Д. Г. и др. Циститы. СПб.; 2006. 127 с.
  4. Nitti V. W., Tu L. M., Gitlin J. Diagnosing bladder outlet obstruction in women. J. Urol. 1999;61:1535-1540.
  5. Andersson K. E. Storage and voiding symptoms: Pathophysiologic aspects. Urology 2003;62:3-10.
  6. Taylor J. A. III, Kuchel G. A. Detrusor underactivity: Clinical features and pathogenesis of an underdiagnosed geriatric condition. J. Am. Geriatr. Soc. 2006; 54:1920-1932.
  7. Boyle P., Robertson C., Mazzetta C. et al.; UrEpik Study Group. The prevalence of lower urinary tract symptoms in men and women in four centres. The UrEpik study. BJU Int. 2003;92(4):409-414.
  8. Pinnock C., Marshall V. R. Troublesome lower urinary tract symptoms in the community: a prevalence study. Med. J. Aust. 1997;167(2):72—75.
  9. Hajebrahimi S., Asrbadr Y. A., Azaripour A., Sadeghi-Bazargan H. Effect of tamsulosin versus prazosin on clinical and urodynamic parameters in women with voiding difficulty: a randomized clinical trial. Int. J. Gen. Med. 2011; 4: 35-39.
  10. Groutz A., Blaivas J. G. Non-neurogenic female voiding dysfunction. Curr. Opin. Urol. 2002;12:311-316.
  11. Groutz A., Gordon D., Lessing J. B. et al. Prevalence and characteristics of voiding difficulties in women: Are subjective symptoms substantiated by objective urodynamic data? Urology 1999;54:268-272.
  12. Diokno A. C., Brock B. M., Brown M. B. et al. Prevalence of urinary incontinence and other urological symptoms in the noninstitutionalized elderly. J. Urol. 1986;136:1022-1025.
  13. Akikwala T. V., Fleischman N., Nitti V. W. Comparison of diagnostic criteria for female bladder outlet obstruction. J. Urol. 2006; 176: 2093-2097.
  14. Pischedda A., Pirozzi Farina F., Madonia M. et al. Use of alpha1-blockers in female functional bladder neck obstruction. Urol. Int. 2005;74(3):256—261.
  15. Chassagne S., Bernier P. A., Haab F. et al. Proposed cutoff values to define bladder outlet obstruction in women. Urology 1998; 51:408-411.
  16. Docherty J. R. Subtypes of functional alpha1-adrenoceptor. Cell. Mol. Life Sci. 2010;67(3):405—417.
  17. Yablonsky F., Riffaud J. P., Lacolle J. Y. et al. Alpha 1- and alpha 2-adrenoceptors in the smooth muscle of male and female rabbit urethra. Eur. J. Pharmacol. 1986;121: 1-8.
  18. Morita T., Latifpour J., O'Hollaren B. et al. Sex differences in function and distribution of alpha 1- and alpha 2-adrenoceptors in rabbit urethra. Am. J. Physiol. 1987;252:F1124-F1128.
  19. Kim N. N., Min K., Huang Y. H. et al. Biochemical and functional characterization of alpha-adrenergic receptors in the rabbit vagina. Life Sci. 2002;71(24):2909—2920.
  20. Nasu K., Moriyama N., Fukasawa R. et al. Quantification and distribution of alpha1-adrenoceptor subtype mRNAs in human proximal urethra. Br. J. Pharmacol. 1998;123:1289-1293.
  21. Okutsu H., Matsumoto S., Hanai T. et al. Effects of tamsulosin on bladder blood flow and bladder function in rats with bladder outlet obstruction. Urology. 2010;75(1):235—240.
  22. Mizuno H., Yamamoto T., Okutsu H. et al. Effect of tamsulosin on bladder microcirculation in a rat ischemia-reperfusion model, evaluated by pencil lens charge-coupled device microscopy system. Urology. 2010;76(5):1266.e1—5.
  23. Mittra S., Malhotra S., Naruganahalli K. S. et al. Role of peripheral 5-HT1A receptors in detrusor over activity associated with partial bladder outlet obstruction in female rats. Eur. J. Pharmacol. 2007;561(1—3):189—193.
  24. Okutsu H., Ohtake A., Ukai M. et al. Effect of tamsulosin on spontaneous bladder contraction in conscious rats with bladder outlet obstruction: comparison with effect on intraurethral pressure. Eur. J. Pharmacol. 2006;545(2—3):185—191.
  25. Yokoyama O., Yusup A., Oyama N. et al. Improvement in bladder storage function by tamsulosin depends on suppression of C-fiber urethral afferent activity in rats. J.Urol. 2007;177(2):771—775.
  26. Bae J. H., Jung P. B., Lee J. G. The effects of alpha-adrenoceptor antagonists on the urethral perfusion pressure of the female rat. BJU Int. 2005;96(7):1131—1135.
  27. Ohtake A., Sato S., Saitoh C. et al. Effects of tamsulosin on hypogastric nerve stimulation-induced intraurethral pressure elevation in male and female dogs under anesthesia. Eur. J. Pharmacol. 2004;497(3):327-334.
  28. Ohtake A., Sato S., Sasamata M. et al. Effects of tamsulosin on resting urethral pressure and arterial blood pressure in anaesthetized female dogs. J. Pharm. Pharmacol. 2006;58(3):345-350.
  29. Reitz A., Haferkamp A., Kyburz T. et al. The effect of tamsulosin on the resting tone and the contractile behaviour of the female urethra: a functional urodynamic study in healthy women. Eur. Urol. 2004;46(2):235—240.
  30. Chang S. J., Chiang I. N., Yu H. J. The effectiveness of tamsulosin in treating women with voiding difficulty. Int. J. Urol. 2008; 15(11):981-985.
  31. Pummangura N., Kochakarn W. Efficacy of tamsulosin in the treatment of lower urinary tract symptoms (LUTS) in women. Asian. J. Surg. 2007;30:131-137.
  32. Costantini E., Lazzeri M., Bini V. et al. Open-label, longitudinal study of tamsulosin for functional bladder outlet obstruction in women. Urol. Int. 2009;83(3):311-315.
  33. Yamanishi T., Yasuda K., Kamai T. et al. Combination of a cholinergic drug and an alpha-blocker is more effective than monotherapy for the treatment of voiding difficulty in patients with underactive detrusor. Int. J. Urol. 2004; 11: 88-96.
  34. Kim S. O., Hwang E. C., Oh K. J. et al. Efficacy and safety of combined therapy with tamsulosin and tolterodine in female patients with a maximal flow rate less than 12 ml/s. Int. Urogynecol. J. 2011;22(10):1287-1291.
  35. Станкович Е. Ю., Борисов В. В., Демина Т. Л. Тамсулозин в лечении детрузорно-сфинктерной диссенергии мочевого пузыря у больных рассеянным склерозом. Урология. 2004;4:48-52.
  36. Mann R. D., Biswas P., Freemantle S. et al. The pharmacovigilance of tamsulosin: event data on 12484 patients. BJU Int. 2000; 85(4):446-450.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Bionika Media, 2012
##common.cookie##